StonvexLoading…
StonvexStonvexStonvexCore line items from PSMT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-02-28 | Q4 2025 2025-11-30 | Annual 2025 2025-08-31 | Q2 2025 2025-05-31 |
|---|---|---|---|---|
Revenue | $2.88B | $1.38B | $5.27B | $3.94B |
Operating Income | $138.35M | $62.93M | $232.51M | $179.76M |
Net Income | $89.26M | $40.17M | $147.89M | $116.35M |
EPS (Diluted) | $2.91 | $1.29 | $4.82 | $3.80 |
Total Assets | $2.44B | $2.39B | $2.27B | $2.14B |
Total Liabilities | $1.10B | $1.09B | $1.02B | $930.25M |
Cash & Equivalents | $156.25M | $206.42M | $241.02M | $167.96M |
Free Cash Flow OCF − CapEx | $44.94M | $32.63M | $103.17M | $77.57M |
Shares Outstanding | 30.90M | 30.82M | 30.75M | 30.75M |